You are here

Article info

Article menu

Download PDFPDF

Protocol
China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design

Authors

  • Liping Liu Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Yilong Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Xuewei Xie Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Dacheng Liu Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Aili Wang Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Penglian Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Suwen Shen Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Chongke Zhong Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Yufei Wei Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Tan Xu Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Yuesong Pan Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Yong Jiang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Xia Meng Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • David Wang Neurovascular Division, Department of Neurology, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, Arizona, USA PubMed articlesGoogle scholar articles
  • Yonghong Zhang Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China PubMed articlesGoogle scholar articles
  • Jiang He Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA PubMed articlesGoogle scholar articles
  • Yongjun Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yongjun Wang; yongjunwang{at}ncrcnd.org.cn; Dr Jiang He; jhe{at}tulane.edu
View Full Text

Citation

Liu L, Wang Y, Xie X, et al
China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
Stroke and Vascular Neurology 2021;6:doi: 10.1136/svn-2020-000828

Publication history

  • Received December 23, 2020
  • Revised February 16, 2021
  • Accepted February 22, 2021
  • First published March 16, 2021.
Online issue publication 
June 29, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.